These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 639160)

  • 21. Biowaiver monographs for immediate release solid oral dosage forms: rifampicin.
    Becker C; Dressman JB; Junginger HE; Kopp S; Midha KK; Shah VP; Stavchansky S; Barends DM
    J Pharm Sci; 2009 Jul; 98(7):2252-67. PubMed ID: 19160441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Clinical Quantitative Evaluation of Hepatobiliary Transport of [
    Kaneko K; Tanaka M; Ishii A; Katayama Y; Nakaoka T; Irie S; Kawahata H; Yamanaga T; Wada Y; Miyake T; Toshimoto K; Maeda K; Cui Y; Enomoto M; Kawamura E; Kawada N; Kawabe J; Shiomi S; Kusuhara H; Sugiyama Y; Watanabe Y
    Drug Metab Dispos; 2018 May; 46(5):719-728. PubMed ID: 29555827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug--excipient interaction in solid pharmaceutical dosage forms].
    Onur E
    Turk Hij Deney Biyol Derg; 1976; 36(1):88-104. PubMed ID: 960234
    [No Abstract]   [Full Text] [Related]  

  • 24. Physiological disposition of 2,6-dimethyl-4-benzyl-4-demethylrifampicin in rats, mice, and dogs.
    Wolpert MK; Lu K; Derr CJ; Loo TL; Johns DG
    Drug Metab Dispos; 1974; 2(3):237-46. PubMed ID: 4153001
    [No Abstract]   [Full Text] [Related]  

  • 25. [Modelling of rifampicin pharmacokinetics in experimental animals administered the drug intravenously and internally].
    Firsov AA; Umnova LV; Stepanov VM; Fomina IP
    Antibiot Med Biotekhnol; 1986 Jun; 31(6):445-9. PubMed ID: 3740826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of rifampicin caplets (600 mg and 450 mg) in healthy Indonesian subjects.
    Ganiswarna SG; Wilmana PF; Setiabudy R; Ringoringo VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):60-4. PubMed ID: 3957493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of bile on the absorption of halofantrine from lipid-based formulations.
    Holm R; Tønsberg H; Jørgensen EB; Abedinpour P; Farsad S; Müllertz A
    Eur J Pharm Biopharm; 2012 Jun; 81(2):281-7. PubMed ID: 22465095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetics of a chloramphenicol-rifampicin combination in rats].
    Cantelli Forti G; Fracasso ME
    Boll Soc Ital Biol Sper; 1971 Oct; 47(19):575-7. PubMed ID: 5140771
    [No Abstract]   [Full Text] [Related]  

  • 29. Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements.
    Cilurzo F; Musazzi UM; Franzé S; Selmin F; Minghetti P
    Drug Discov Today; 2018 Feb; 23(2):251-259. PubMed ID: 29030242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacokinetics of rifampicin in experimental animals].
    Koroleva VG; Fomina IP
    Antibiotiki; 1976 Aug; 21(8):722-5. PubMed ID: 999253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correlations between the biological properties and structure of rifampicin].
    Sensi P
    G Ital Mal Torace; 1969; ():Suppl 2:40-9. PubMed ID: 5357138
    [No Abstract]   [Full Text] [Related]  

  • 32. Corneal penetration of rifampin.
    Feldman MF; Moses RA
    Am J Ophthalmol; 1977 Jun; 83(6):862-5. PubMed ID: 326055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biopharmaceutical classification system--experimental model of the prediction of drug bioavailability].
    Golovenko NIa; Borisiuk IIu
    Biomed Khim; 2008; 54(4):392-407. PubMed ID: 18988456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of fatal poisoning by rifampicin.
    Plomp TA; Battista HJ; Unterdorfer H; van Ditmarsch WC; Maes RA
    Arch Toxicol; 1981 Nov; 48(4):245-52. PubMed ID: 7316759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacokinetics of rifampicin.
    Acocella G
    Clin Pharmacokinet; 1978; 3(2):108-27. PubMed ID: 346286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bioavailability of raubasine in various pharmaceutical forms in the dog].
    Castoldi D; Chinea B; Montanari P
    Farmaco Prat; 1976 Nov; 31(11):580-5. PubMed ID: 1017471
    [No Abstract]   [Full Text] [Related]  

  • 37. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance.
    Agrawal S; Ashokraj Y; Bharatam PV; Pillai O; Panchagnula R
    Eur J Pharm Sci; 2004 Jun; 22(2-3):127-44. PubMed ID: 15158898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of the excretion in bile and concentration in the gall bladder wall of rifamide.
    Acocella G; Lamarina F; Tenconi LT; Nicolis FB
    Gut; 1966 Aug; 7(4):380-6. PubMed ID: 5917425
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of various cytochrome P450 3A and P-glycoprotein modulators on the biliary clearance of bromosulphaphthalein in male wistar rats.
    Machavaram KK; Gundu J; Yamsani MR
    Pharmazie; 2004 Dec; 59(12):957-60. PubMed ID: 15638086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel rifampicin-phospholipid complex for tubercular therapy: synthesis, physicochemical characterization and in-vivo evaluation.
    Singh C; Bhatt TD; Gill MS; Suresh S
    Int J Pharm; 2014 Jan; 460(1-2):220-7. PubMed ID: 24188983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.